Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Speece Thorson Capital Group Inc.

Speece Thorson Capital Group Inc. trimmed its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 97.0% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,024 shares of the company's stock after selling 229,891 shares during the quarter. Speece Thorson Capital Group Inc.'s holdings in Henry Schein were worth $481,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Investment Management Corp VA ADV purchased a new position in shares of Henry Schein in the 4th quarter worth about $32,000. Rakuten Securities Inc. purchased a new stake in shares of Henry Schein during the 1st quarter valued at about $34,000. UMB Bank n.a. raised its holdings in shares of Henry Schein by 23.2% during the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after buying an additional 201 shares during the period. Allworth Financial LP raised its holdings in shares of Henry Schein by 24.5% during the 1st quarter. Allworth Financial LP now owns 1,178 shares of the company's stock valued at $78,000 after buying an additional 232 shares during the period. Finally, Menard Financial Group LLC purchased a new stake in shares of Henry Schein during the 4th quarter valued at about $92,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on HSIC. Piper Sandler dropped their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Wall Street Zen downgraded Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Wells Fargo & Company dropped their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Robert W. Baird reiterated a "neutral" rating and set a $72.00 target price (down from $82.00) on shares of Henry Schein in a report on Monday. Finally, Baird R W downgraded Henry Schein from a "strong-buy" rating to a "hold" rating in a report on Monday. Eight analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $78.36.

Henry Schein Stock Down 1.9%

NASDAQ HSIC traded down $1.32 during mid-day trading on Wednesday, reaching $69.32. 2,134,933 shares of the company's stock traded hands, compared to its average volume of 1,748,391. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The company has a fifty day simple moving average of $71.79 and a 200-day simple moving average of $71.32. The company has a current ratio of 1.38, a quick ratio of 0.75 and a debt-to-equity ratio of 0.50. The company has a market cap of $8.44 billion, a price-to-earnings ratio of 21.66, a P/E/G ratio of 2.28 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same quarter last year, the firm earned $1.10 EPS. Henry Schein's quarterly revenue was down .1% on a year-over-year basis. As a group, equities research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.